Literature DB >> 9105896

Ontogenetic expression of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendocrine system.

S C Barkatullah1, W J Curry, C F Johnston, J C Hutton, K D Buchanan.   

Abstract

The ontogenetic expression of chromogranin A (CgA) and its derived peptides, WE-14 and pancreastatin (PST), was studied in the rat neuroendocrine system employing immunohistochemical analysis of fetal and neonatal specimens from 12.5-day embryos (E12.5), to 42-day postnatal (P42) rats. CgA immunostaining was first detected in endocrine cells of the pancreas, stomach, intestine, adrenal gland and thyroid at E13.5, E14.5, E15.5, E15.5 and E18.5, respectively. PST-like immunoreactivity was detected in endocrine cells of the pancreas at E13.5, stomach, intestine at E15.5, adrenal gland at E17.5 and thyroid at E18.5. WE-14 immunoreactivity was first observed in the immature pancreas at E15.5, mucosal cells of the stomach at E15.5, scattered chromaffin cells in the immature adrenal gland and mucosal cells of the intestine at E17.5 and thyroid parafollicular cells at E18.5. These data confirm that the translation of the CgA gene is regulated differentially in various neuroendocrine tissues and, moreover, suggests that the post-translational processing of the molecule is developmentally controlled.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105896     DOI: 10.1007/s004180050110

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  2 in total

1.  Single Cell Peptide Heterogeneity of Rat Islets of Langerhans.

Authors:  Erik T Jansson; Troy J Comi; Stanislav S Rubakhin; Jonathan V Sweedler
Journal:  ACS Chem Biol       Date:  2016-07-29       Impact factor: 5.100

2.  N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.

Authors:  Niyun Jin; Yang Wang; Frances Crawford; Janice White; Philippa Marrack; Shaodong Dai; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-09       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.